Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer

Published:2006-10-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kumar Satish¹,Shelley Mike²,Harrison Craig³,Coles Bernadette⁴,Wilt Timothy J.⁵,Mason Malcolm⁶

Affiliation:

1. Singleton Hospital; Department of Oncology; Sketty Lane Swansea Wales UK SA2 8QA

2. Velindre NHS Trust; Cochrane Prostatic Diseases and Urological Cancers Unit, Research Dept; Velindre Road Whitchurch Cardiff Wales UK CF4 7XL

3. Velindre NHS Trust; Cardiff Wales UK CF14 2TL

4. Cardiff University; Cancer Research Wales Library; Velindre Cancer Centre Whitchurch Cardiff UK CF14 2TL

5. VAMC; General Internal Medicine (111-0); One Veterans Drive Minneapolis Minnesota USA 55417

6. Velindre Hospital; Clinical Oncology; Whitchurch Cardiff UK CF4 7XL

Publisher

Wiley

Subject

Pharmacology (medical)

Reference110 articles.

1. The risk of malignancy in the surgical margin at radical prostatectomy reduced almost three-fold in patients given neo-adjuvant hormone treatment;Hugosson;European Urology,1996

2. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial;Bolla;Lancet,2002

3. Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer;Crook;International Journal of Radiation Oncology, Biology, Physics,2004

4. Randomized study of neoadjuvant testicular androgen ablation therapy before radical prostatectomy in men with clinically localized prostate cancer;Dalkin;Journal of Urology,1996

5. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial;Denham;Lancet Oncology,2005

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives;Clinical Genitourinary Cancer;2024-10

2. PRIORITI: Phase 4 study of triptorelin or active surveillance in high‐risk prostate cancer;Asia-Pacific Journal of Clinical Oncology;2024-07-03

3. The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review;Minerva Urology and Nephrology;2024-05

4. Economic Evaluation of Neoadjuvant Versus Adjuvant Chemotherapy in Cancer Treatment: A Systematic Review and Meta-Analysis;Value in Health Regional Issues;2024-05

5. Salvage Androgen Deprivation Therapy as Potential Treatment for Recurrence after Robot-Assisted Radical Prostatectomy;Cancers;2024-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3